Dupilumab is Effective in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities

Mark Boguniewicz, Lawrence Sher, Amy Paller, Peter Arkwright, Shigemi Yoshihara, Wendy Smith Begolka, Zhen Chen, Parul Shah, Ainara Rodríguez Marco

Open source

DOI
10.2147/jaa.s590176
Published
2026-05
Container
Journal of Asthma and Allergy
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/jaa.s590176,
  title = {Dupilumab is Effective in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities},
  author = {Mark Boguniewicz and Lawrence Sher and Amy Paller and Peter Arkwright and Shigemi Yoshihara and Wendy Smith Begolka and Zhen Chen and Parul Shah and Ainara Rodríguez Marco},
  year = {2026},
  journal = {Journal of Asthma and Allergy},
  doi = {10.2147/jaa.s590176},
  url = {https://doi.org/10.2147/jaa.s590176}
}

RIS

TY  - JOUR
TI  - Dupilumab is Effective in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities
AU  - Mark Boguniewicz
AU  - Lawrence Sher
AU  - Amy Paller
AU  - Peter Arkwright
AU  - Shigemi Yoshihara
AU  - Wendy Smith Begolka
AU  - Zhen Chen
AU  - Parul Shah
AU  - Ainara Rodríguez Marco
PY  - 2026
JO  - Journal of Asthma and Allergy
DO  - 10.2147/jaa.s590176
UR  - https://doi.org/10.2147/jaa.s590176
ER  - 

APA

Boguniewicz, M., Sher, L., Paller, A., Arkwright, P., Yoshihara, S., Begolka, W. S., Chen, Z., Shah, P., & Marco, A. R. (2026). Dupilumab is Effective in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities. Journal of Asthma and Allergy. https://doi.org/10.2147/jaa.s590176

Source records